Physician profile
Michael Sheehan
NPI 1790822518
$2,676.67
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,240 · 2022: $43.63 · 2023: $50.01 · 2024: $1,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $965 · Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $964.64 |
| Food and Beverage | $428.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,328.70 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Astellas Pharma US INC | $259.35 | 2021 | |
| Myovant Sciences INC. | $183.00 | 2021-2022 | |
| Janssen Biotech, INC. | $179.00 | 2021 | |
| Abbvie INC. | $176.60 | 2021-2023 | |
| Endo Pharmaceuticals INC. | $156.88 | 2021 | |
| Urogen Pharma, INC. | $99.21 | 2021 | |
| Amgen INC. | $58.14 | 2021 | |
| Allergan, INC. | $42.34 | 2021 | |
| Axonics, INC. | $37.76 | 2021-2022 | |
| Baxter Healthcare | $36.10 | 2023 | Floseal |
| Genzyme Corporation | $24.88 | 2021 | |
| Therapeuticsmd, INC. | $24.14 | 2021 | |
| Pfizer INC. | $22.10 | 2021 | |
| Angiodynamics, INC. | $21.55 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $14.00 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Bayer Healthcare Pharmaceuticals INC. | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sheehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.